Tag Archives: TB drugs

New MDR-TB Study Highlights the Promise of R&D in Fight Against Deadly Bug

By on .

In a small new study, researchers found that linezolid, an antibiotic first approved in 2000, may be an effective component in the treatment of multidrug-resistant drug-resistant tuberculosis. But as previous research of this drug has suggested, linezolid is far from a perfect cure for the global epidemic of drug-resistant TB, and the findings reinforce the […]

NIAID’s Fauci on Tuberculosis: “We have much catching up to do”

By on .

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, delivered a forceful message on the need for a “storm” of attention and resources devoted to developing new TB treatment and prevention efforts. “It is imperative that we transform the way we diagnose, treat, prevent, and control TB — through biomedical research and […]

FDA Panel Says Threat of MDR-TB Warrants Fast-Track for New Drugs

By on .

A Food and Drug Administration advisory committee has decided that the threat posed by MDR-TB merits a fast-track approval process for potential new treatments. The clock is ticking, as drug-resistant TB spreads across the globe and scientists search for new drugs to combat this virulent germ. Given that background, the FDA’s Anti-Infective Drugs Advisory Committee […]

Two Tales on TB

By on .

Two troubling TB stories this morning: First, a study in the Lancet reports that MDR-TB is an increasing threat in the former Soviet Union and China. “The countries of the former Soviet Union are facing a serious and widespread epidemic with the highest prevalence of MDR-TB ever reported in 13 years of global data collection,” […]